An interventional study of Active rocking in a rocking chair and Sitting upright in a stationary chair in Postoperative Care, sponsored by University of Missouri, Kansas City. Not yet recruiting. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-04-27.
Sponsored by University of Missouri, Kansas City · Not applicable, Interventional, and Supportive care
Feasibility and acceptability randomized controlled trial exploring the use of a rocking chair after a total hip arthroplasty in adults who are aged 65 or older. Primary aims include its feasibility and acceptability; exploratory aims include the impact of rocking on pain, gastrointestinal effects, anxiety, ambulation, and additional healthcare visits.
University of Missouri, Kansas City is the lead sponsor of 48 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Rocking chair intervention
Behavioral: Active rocking in a rocking chair
Sitting upright in stationary chair
Behavioral: Sitting upright in a stationary chair
Participants will actively rock 3 times per day for 30 minutes in a rocking chair
Also known as: Rocking
Participants will sit upright in a stationary chair 3 times per day for 30 minutes
Also known as: Sitting
Number of participants that enroll and complete study assessed by Feasibility Participant Questionnaire (developed by investigators)
Feasibility of active rocking post-operative measured by total number of participants enrolled, total percentage and number completing the study, and percent of missing data. A higher percent of missing data is a negative outcome.
Time frame: From enrollment to 31-day follow-up
Total participants reporting acceptability of rocking or sitting as measured by Acceptability for Participants Questionnaire
Acceptability of rocking or sitting after hip arthroplasty indicated by score on domains of affective, perceived effectiveness, intervention coherence, ethicality, burden, opportunity costs, self-efficacy likert scales from 1-4 (Not at all, a little, somewhat, very much). Scores from each domain are combined and summed to determine a single acceptability score (higher scores equate to higher acceptability of the intervention).
Time frame: From enrollment to 31-day follow-up
Total participants indicating Nausea using the PROMIS Scale v1.0 GI Nausea and Vomiting 4A
Participants indicate Daily nausea assessment on 5-point Likert scale (never, rarely, sometimes, often, always). Higher scores indicate more Nausea.
Time frame: From surgery (Day 1 of the study) to 31-day follow-up
Total participants reporting Gas/bloating via PROMIS v1.1 GI Gas and Bloating 13A
Participants reporting Daily gas/bloating assessment on 5-point Likert scale (not at all, a little bit, somewhat, quite a bit, very much). Higher scores indicate more daily gas/bloating.
Time frame: From surgery (Day 1 of the study) to end of 31-day follow-up
Total participants reporting Daily pain assessed by PROMIS v2.0 pain intensity 3A
Participants reporting Daily pain assessment on 5-point likert scale (no pain, mild, moderate, severe, very severe). Higher scores equate to more daily pain experienced.
Time frame: From surgery (Day 1 of the study) to end of 31-day follow-up
Total amount of participants' Daily Ambulation as measured using steps via activPAL4pro accelerometer
The amount of participants' Daily ambulation will be assessed with the amount of steps taken per day using the triaxial accelerometer activPAL4pro. More steps per day equates to greater ambulation.
Time frame: After surgery (Day 1 of the study) and up to 7 days post-surgery
Total amount of participants' Daily anxiety measured using the Anxiety subscale of the Neuro-QoL Hospital Anxiety and Depression Scale
The participants will report their Daily anxiety assessment using the Anxiety subscale of the Neuro-QoL Hospital Anxiety and Depression Scale, which assesses self-reported fear, worry, tension, and nervousness and will be scored with a T-score with higher scores indicating more anxiety. The scores range from 0-3 (not at all, not often, sometimes, most of the time).
Time frame: From enrollment through 31-day follow-up
Participants' self-reported Additional healthcare visits since their surgery, as assessed via phone call at 31-days post-surgery
The total number of Additional healthcare visits will be assessed via phone call at 31-days post-surgery using the investigator-developed question: Have you been hospitalized since you have been discharged from your hip surgery?
Time frame: From surgery (Day 1 of the study) until 31-day follow-up
No study locations are listed for this record.
Plan to share: Yes — Will provide de-identified data to other researchers if a reasonable request is made
Supporting information: Study protocol
Time frame: Start date: March 2026 End date: up to 7 years after study ends
Access criteria: Study investigators will be able to access the IPD after it has been de-identified. They will access via password protected files.
No publications or documents are linked to this record.
Start is estimated for May 2026; primary completion for Sep 2026, 4 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Missouri, Kansas City